MedPath

The Effects of Chiropractic in Adults With Metabolic Syndrome

Not Applicable
Suspended
Conditions
Metabolic Syndrome
Interventions
Procedure: Chiropractic adjustment
Registration Number
NCT05884437
Lead Sponsor
Life University
Brief Summary

The purpose of this study is to assess the feasibility of our study procedures/protocols and to look at the potential effects of chiropractic care on people with metabolic syndrome.

Detailed Description

After providing informed consent, individuals will undergo 6 weeks of chiropractic care. Throughout these 6 weeks there will be three assessments (Day 0, Week 2, and Week 6) that each include the following:

1. Seated resting recording

2. Auditory oddball task

3. Isometric hand grip

4. Postural challenge

5. Treadmill walking

6. Patient-reported outcome surveys

Each assessment will consist of the following recordings:

1. Electroencephalography \[EEG\]

2. Electrodermal activity \[EDA\]

3. Impedance cardiography \[ICG\]

4. Electrocardiogram \[ECG\]

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Individuals over the age of 18

  • Individuals who can wear an EEG net for 30 minutes

  • Individuals who can sit quietly for at least 15 minutes

  • Individuals who can walk unassisted for up to 10 minutes

  • Individuals who can provide informed consent

  • Individuals who meet 3 of the 5 following criteria:

    • Elevated waist circumference (>40 in/102 cm if male and >35 in/88cm if female)
    • Elevated triglycerides (>150 mg/dL) or drug treatment for elevated triglycerides
    • Reduced HDL-cholesterol (<40mg/dL if male and <50 mg/dL if female) or drug treatment to increase HDL-C
    • Elevated blood pressure (>130 mm Hg systolic BP or >85 mm Hg diastolic BP) or drug treatment to reduce blood pressure
    • Elevated fasting glucose (>100 mg/dL) or drug treatment to reduce blood glucose
Exclusion Criteria
  • Individuals with a known disorder resulting in syncope/fainting during postural changes (e.g., POTS, orthostatic hypotension)
  • Individuals with impaired function of the dominant hand
  • Individuals with malignant hypertension
  • Individuals with a known heart condition such as arrhythmia that results in an aberrant ECG recording
  • Individuals with any implanted devices (i.e., pacemakers)
  • Individuals with brain aneurysms
  • Individuals with a history of epilepsy or stroke that would influence EEG readings
  • Individuals with a diagnosed externalizing or thought disorder (i.e., anti-social disorder, any major personality disorder such as borderline personality disorder, or schizophrenia)
  • Individuals who are on short-acting benzodiazepines which include midazolam & triazolam
  • Individuals with any serious injury or surgery to the head or torso, or lower body in the last 6 months
  • Individuals with a hearing impairment or hearing aids (due to the auditory stimulus recording being performed)
  • Individuals who are currently pregnant
  • Individuals with current litigation related to a physical, health-related injury
  • Individuals who have been diagnosed with rheumatoid arthritis, osteoporosis or instability of the neck.
  • Individuals with moderate to severe pain on a daily basis
  • Pain on the day of testing rated greater than 3/10 on a visual analog scale (VAS)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ChiropracticChiropractic adjustmentChiropractic adjustment
Primary Outcome Measures
NameTimeMethod
Acceptability of treatment regimen for participantsWeek 6

9-item acceptability questionnaire

Recruitment ratethrough study completion, an average of 1 year

Length of time needed to recruit target number of participants

Participant adherence ratethrough study completion, an average of 1 year

Proportion of participants able to adhere to the testing \& treatment schedule

Participant retention ratethrough study completion, an average of 1 year

Proportion of enrolled participants who complete the full testing regimen

Participant tolerability ratethrough study completion, an average of 1 year

Proportion of participants able to perform all aspects of the testing regimen

Secondary Outcome Measures
NameTimeMethod
EEG resting state functional connectivityWeek 6

64-channel hydronet cap

EEG evoked latencyWeek 6

64-channel hydronet cap during auditory oddball task

ECG respiratory sinus arrhythmia (RSA)Week 6

3 sensors on torso

Electrodermal activity (EDA) power spectral density (PSD)Week 6

2 sensors on first and second digits of non-dominant hand

Composite Autonomic Symptom Score COMPASS-31)Day 1

31-item questionnaire

EEG evoked amplitudeWeek 6

64-channel hydronet cap during auditory oddball task

skin conductance level (SCL)Week 6

2 electrodermal activity (EDA) sensors on first and second digits of non-dominant hand

ECG mean interbeat intervalWeek 6

3 sensors on torso

EEG resting state broadband powerWeek 6

64-channel hydronet cap

Composite Autonomic Symptom Score (COMPASS-31)Week 6

31-item questionnaire

Patient-Reported Outcomes Measurement Information System Cognitive Abilities and Cognitive Concerns Scale (PROMIS-Cog)Week 6

8-item questionnaire

Perceived Stress Scale (PSS)Week 6

10-item questionnaire

Impedance cardiogram (ICG) pre-ejection period (PEP)Week 6

2 sensors on chest and 2 sensors on back

ECG de-trended fluctuation analysisWeek 6

3 sensors on torso

Impedance cardiogram (ICG) initial systolic time interval (ISTI)Week 6

2 sensors on chest and 2 sensors on back

Electrodermal activity (EDA) non-specific skin conductance responses (SCR)Week 6

2 sensors on first and second digits of non-dominant hand

Trial Locations

Locations (1)

Dr. Sid E. Williams Center for Chiropractic Research

🇺🇸

Marietta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath